Zacks: Analysts Expect Stericycle Inc (SRCL) Will Announce Quarterly Sales of $880.25 Million
Wall Street brokerages expect Stericycle Inc (NASDAQ:SRCL) to post $880.25 million in sales for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for Stericycle’s earnings. The highest sales estimate is $907.60 million and the lowest is $858.50 million. Stericycle posted sales of $906.40 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 2.9%. The firm is expected to report its next earnings results on Wednesday, February 21st.
On average, analysts expect that Stericycle will report full year sales of $880.25 million for the current financial year, with estimates ranging from $3.55 billion to $3.60 billion. For the next financial year, analysts anticipate that the business will post sales of $3.64 billion per share, with estimates ranging from $3.57 billion to $3.77 billion. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that that provide coverage for Stericycle.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Wednesday, November 8th. The business services provider reported $1.10 EPS for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). The company had revenue of $883.00 million during the quarter, compared to the consensus estimate of $896.81 million. Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. Stericycle’s quarterly revenue was down .8% on a year-over-year basis. During the same period in the previous year, the company earned $1.24 EPS.
Stericycle (NASDAQ SRCL) opened at $72.20 on Thursday. The company has a market cap of $6,160.51, a price-to-earnings ratio of -126.66, a PEG ratio of 1.75 and a beta of 0.16. Stericycle has a twelve month low of $61.25 and a twelve month high of $88.00. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.93.
In other news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction on Monday, November 13th. The shares were sold at an average price of $64.03, for a total value of $1,264,784.59. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 79,012 shares of company stock valued at $5,240,668 in the last ninety days. 3.50% of the stock is owned by corporate insiders.
Several institutional investors have recently made changes to their positions in the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Stericycle by 0.4% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,335 shares of the business services provider’s stock valued at $483,000 after purchasing an additional 24 shares in the last quarter. Sentry Investment Management LLC boosted its position in Stericycle by 1.1% during the 2nd quarter. Sentry Investment Management LLC now owns 6,418 shares of the business services provider’s stock valued at $490,000 after buying an additional 70 shares during the period. State of Tennessee Treasury Department boosted its position in Stericycle by 0.4% during the 2nd quarter. State of Tennessee Treasury Department now owns 23,321 shares of the business services provider’s stock valued at $1,780,000 after buying an additional 87 shares during the period. AXA boosted its position in Stericycle by 1.0% during the 2nd quarter. AXA now owns 10,489 shares of the business services provider’s stock valued at $801,000 after buying an additional 100 shares during the period. Finally, EagleClaw Capital Managment LLC boosted its position in Stericycle by 0.8% during the 2nd quarter. EagleClaw Capital Managment LLC now owns 23,880 shares of the business services provider’s stock valued at $1,821,000 after buying an additional 200 shares during the period. 94.49% of the stock is owned by institutional investors.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.